The level of miR-146a is increased in RA patients who respond well to anti-TNF therapy and, interestingly, can be considered as predictors of the response to anti-TNFα therapy together with CRP (24, 111, 112). The gene discussed is CRP; the disease is rheumatoid arthritis.